ivWatch Closing Out a Busy Spring Schedule at the AONL and NTI 2023 Conferences in May

ivWatch Doubled its Event Footprint from 2022 to Prominently Display the Only Continuous Patient Monitoring System to Detect Infiltrations

Newport News, VA, May 1, 2023– ivWatch, LLC is changing the way of patient monitoring through the use of advanced biosensor technology for the early detection of infiltration events. IV complications are unpredictable and not preventable, but if they are detected early, patients can be protected from significant injury.  

 

The American Organization for Nursing Leadership will be hosting their premier event for attendees in Anaheim, CA May 1-4, 2023. ivWatch returns to this dynamic meeting for two consecutive years to meet with clinical leadership. The ivWatch team will be offering in-person demonstrations of the Patient Monitoring System, including its SmartTouch biosensor in booth 242. The ivWatch system is the only FDA cleared technology to detect infiltrations often before visual signs are prevalent.  

 

The American Association of Critical Care Nurses will hold their annual, primary conference, NTI, for critical care nurses in Philadelphia, PA on May 22-24, 2023. ivWatch is excited to return to NTI year after year to meet with nurses at all skill levels and discuss continuous IV monitoring. This year ivWatch will host an ExpoEd session in their booth on Tuesday, May 23 at 11:30am and 1:45pm and Wednesday May 24 at 10:45am and 1:00pm. Stop by booth 1648 and hear Clinical Director, Eric Hamre, discuss real life data in his talk The Dangers of IV Infiltrations: 50 Global Hospital Evaluations Revealed. 

 

Continue to check on ivWatch’s site for more information about upcoming events. For a preview of the technology visit: https://www.ivwatch.com/tech-overview/ 

 

About ivWatch, LLC 
ivWatch, LLC  is a biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is pioneering the use of optical sensors to detect adverse IV events early to minimize the risk of injury caused by infiltrations and extravasations. By using this technology, clinicians can leverage continuous monitoring to help identify infiltrations as early as possible. Our innovative IV site monitoring solutions are backed by decades of clinical research and device development. To learn more, follow us on Twitter @ivWatch, Facebook @ivWatchLLC, and LinkedIn @ivWatch-LLC, or visit  www.ivWatch.com. 

 

MEDIA CONTACT: 
Erin Wendell 
erin.wendell@ivwatch.com 
Mobile (410) 952-3800 

 

Meet us at NICA | June 21st - June 22nd | **BOOK TODAY**
Meet us at NICA | June 21st - June 22nd | **BOOK TODAY**